Molecular Docking and Pharmacological In Silico Evaluation of Genistein and Hematoxylin as Promising Ribonucleotide Reductase-targeted Therapies for Cancer.
来源：PubMed发布日期：2026-07-29作者：Deli Khudhair O, Zabidi MA, Gazzali AM, Mohd Najib MN, Maryoosh TM0 次点击